Cresco Labs (CRLBF)

Cresco Labs Stock Analysis & Ratings

CRLBF Stock Chart & Stats

Day’s Range$3.88 - $4.2
52-Week Range$3.80 - $12.88
Previous Close$3.98
Average Volume (3M)572.91K
Market Cap$849.62M
P/E Ratio-3.4
Next EarningsAug 25, 2022
Next Dividend Ex-DateN/A
Dividend YieldN/A
Smart Score6
EPS (TTM)-1.19



P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.



What was Cresco Labs’s price range in the past 12 months?
Cresco Labs lowest stock price was $3.80 and its highest was $12.88 in the past 12 months.
    What is Cresco Labs’s market cap?
    Cresco Labs’s market cap is $849.62M.
      What is Cresco Labs’s price target?
      The average price target for Cresco Labs is $10.36. This is based on 10 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
      The highest analyst price target is $14.80 ,the lowest forecast is $3.89. The average price target represents 153.30% Increase from the current price of $4.09.
        What do analysts say about Cresco Labs?
        Cresco Labs’s analyst rating consensus is a ‘Strong Buy. This is based on the ratings of 10 Wall Streets Analysts.
          When is Cresco Labs’s upcoming earnings report date?
          Cresco Labs’s upcoming earnings report date is Aug 25, 2022 which is in 96 days.
            How were Cresco Labs’s earnings last quarter?
            Cresco Labs released its earnings results on May 18, 2022. The company reported -$0.05 earnings per share for the quarter, missing the consensus estimate of $0.001 by -$0.051.
              Is Cresco Labs overvalued?
              According to Wall Street analysts Cresco Labs’s price is currently Undervalued.
                Does Cresco Labs pay dividends?
                Cresco Labs does not currently pay dividends.
                What is Cresco Labs’s EPS estimate?
                Cresco Labs’s EPS estimate for its next earnings report is not yet available.
                How many shares outstanding does Cresco Labs have?
                Cresco Labs has 207,730,000 shares outstanding.
                  What happened to Cresco Labs’s price movement after its last earnings report?
                  Cresco Labs reported an EPS of -$0.05 in its last earnings report, missing expectations of $0.001. Following the earnings report the stock price went down -1.026%.
                    Which hedge fund is a major shareholder of Cresco Labs?
                    Currently, no hedge funds are holding shares in CRLBF


                    Cresco Labs Stock Analysis

                    The Cresco Labs stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                    Learn more about TipRanks Smart Score

                    Company Description

                    Cresco Labs

                    Cresco Labs Inc is a Canada based company engaged in the production and sale of cannabis. The company distribute its products to dispensaries nationwide, including several dispensaries owned and operated by its team. Its product includes Reserve, Remedi, Mindy's. All the revenues of the company were generated in the United States. It has ownership interests in Illinois, Pennsylvania, Ohio, California, Maryland, and Arizona.

                    Similar Stocks
                    Price & Change
                    Green Thumb Industries
                    Curaleaf Holdings
                    Trulieve Cannabis

                    Popular Stocks

                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis